regulatory
confidence high
sentiment positive
materiality 0.70
BioCardia, Inc. (BCDA): Nasdaq/NYSE listing notice — BioCardia regains Nasdaq minimum equity compliance after $4.9M ATM raise
BioCardia, Inc.
- Nasdaq extended compliance deadline to Oct 7, 2026 after company submitted plan to regain minimum $2.5M equity.
- Raised ~$4.9M net through ATM sale of 4.0M shares at avg $1.27 from Apr 1 to Jun 5, 2026.
- Company believes stockholders' equity now exceeds $2.5M, meeting Nasdaq continued listing requirement.
- Nasdaq will monitor compliance; delisting risk remains if not sustained at next periodic report.